feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Tata Sierra launched in India

trending

Celina Jaitly alleges domestic violence

trending

iPhone 16 Flipkart Black Friday

trending

Income tax refund delays explained

trending

AIFF enforces Supreme Court order

trending

ChatGPT rolls out shopping tool

trending

26/11 terror case: Acquittal

trending

Tornado hits Houston area

trending

Stranger Things season 5 release

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Weight Regain Shock: Jabs Fail Long-Term?

Weight Regain Shock: Jabs Fail Long-Term?

24 Nov

•

Summary

  • Most users regain weight after stopping weight loss jabs.
  • Significant weight rebound observed even with lifestyle changes.
  • Health benefits diminish as weight is regained.
Weight Regain Shock: Jabs Fail Long-Term?

New research indicates that the majority of individuals using weight loss injections like Mounjaro experience significant weight regain after cessation. An international trial found that 82% of participants regained at least a quarter of their lost weight within a year of stopping the medication, despite maintaining reduced-calorie diets and increased physical activity.

The study, published in JAMA Internal Medicine, also highlighted that this weight rebound correlates with a decline in health benefits, including worsened cholesterol levels and fasting insulin. Increased blood pressure was also noted, elevating the risk of stroke among those who regained weight.

These findings underscore the ongoing challenge of obesity management, suggesting that continuous treatment may be necessary. With millions in Britain using such injections, this research raises important questions about the long-term efficacy and implications of these popular weight loss medications.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Approximately 82% of people regained at least 25% of their lost weight after stopping Mounjaro.
While lifestyle changes were part of the trial, significant weight regain still occurred, indicating they were not sufficient alone.
Regaining weight can decrease health improvements and increase risks such as higher blood pressure and stroke.

Read more news on

Healthside-arrow

You may also like

Ozempic's Hidden Face: Does it Speed Up Wrinkles?

7 hours ago

article image

Doctor Warns: Your Sleep Position May Cause Chest Pain

23 Nov • 4 reads

article image

Smriti Mandhana's Wedding Postponed Due to Father's Health Emergency

23 Nov • 4 reads

article image

Miracle Heart Transplant Saves Man's Life in Visakhapatnam

19 Nov • 38 reads

article image

Teladoc Health Navigates Shifting Landscape: Integrated Care Grows, BetterHelp Shrinks

17 Nov • 25 reads

article image